Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 178. Myeloproliferative Disorders
Topics: Introduction | Polycythemia Vera | Myelofibrosis | Thrombocythemia
 
green line

Introduction

In myeloproliferative disorders (myelo = bone marrow, proliferative = rapid multiplication), the blood-producing cells in the bone marrow (precursor cells) develop and reproduce abnormally or are crowded out by an overgrowth of fibrous tissue.

Three major myeloproliferative disorders are polycythemia vera, myelofibrosis, and thrombocythemia. The proliferation of blood-producing cells is always clinically noncancerous (benign) when it begins. However, in a small number of people, a myeloproliferative disorder progresses or transforms to a cancerous (malignant) condition (leukemia).

click here to view the table See the table Major Myeloproliferative Disorders.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.